Short on SANOFI (SAN)Short until 87.0 (support zone).
Strong selling pressure confirmed by two large red candles.
Recent green candle shows buyer hesitation (small body, upper wick).
No significant volume to support a bullish rebound.
RSI remains weak but needs surveillance.
Rebound lacking conviction.
95.90 MXN
120.01 B MXN
886.68 B MXN
1.11 B
About SANOFI
Sector
Industry
CEO
Paul Hudson
Website
Headquarters
Paris
Founded
1994
ISIN
FR0000120578
FIGI
BBG011XP5990
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
Sanofi (SNY): A Strong Investment CaseCompany Overview:
Sanofi NASDAQ:SNY is a major pharmaceutical company based in Paris, with a market capitalization of $134 billion.
Investment Highlights:
Dividend Yield: 3.8%, more than double the S&P 500 average.
Drug Portfolio: Diverse and includes successful drug developments.
Pipeline: Prom
Is Sanofi Undervalue by 22% ?I wanted to share an analysis I've conducted on Sanofi over the past five years using both comparable methods and a 2-Stage DCF approach. According to my findings, the market value appears to be at least 22% undervalued in comparison with its fair value. Moreover, considering the post-COVID effects
Sanofi S.A. (SAN.pa) bearish scenario:The technical figure Channel Up can be found in the daily chart in the French company Sanofi S.A. (SAN.pa). Sanofi S.A. is a French multinational pharmaceutical and healthcare company. Sanofi engages in the research and development, manufacturing and marketing of pharmacological products, principall
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
US801060AD6
SANOFI SA 18/28Yield to maturity
4.31%
Maturity date
Jun 19, 2028
FR1332437
SANOFI 18/38 MTNYield to maturity
3.73%
Maturity date
Mar 21, 2038
FR1340985
SANOFI 19/34 MTNYield to maturity
3.29%
Maturity date
Mar 21, 2034
FR1400Y1I
SANOFI 25/31 MTNYield to maturity
2.88%
Maturity date
Mar 11, 2031
FR1400Y1H
SANOFI 25/27 FLR MTNYield to maturity
2.87%
Maturity date
Mar 11, 2027
FR1332435
SANOFI 18/30 MTNYield to maturity
2.77%
Maturity date
Mar 21, 2030
FR1340984
SANOFI 19/29 MTNYield to maturity
2.68%
Maturity date
Mar 21, 2029
FR1350511
SANOFI 20/30 MTNYield to maturity
2.66%
Maturity date
Apr 1, 2030
FR14009KQ
SANOFI 22/29 MTNYield to maturity
2.58%
Maturity date
Apr 6, 2029
FR1332434
SANOFI 18/26 MTNYield to maturity
2.40%
Maturity date
Mar 21, 2026
FR1320163
SANOFI 16/27 MTNYield to maturity
2.38%
Maturity date
Jan 13, 2027
See all SAN1/N bonds
Curated watchlists where SAN1/N is featured.
Related stocks
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange SANOFI stocks are traded under the ticker SAN1/N.
SAN1/N stock has fallen by −1.32% compared to the previous week, the month change is a −1.32% fall, over the last year SANOFI has showed a −1.32% decrease.
We've gathered analysts' opinions on SANOFI future price: according to them, SAN1/N price has a max estimate of 2,785.41 MXN and a min estimate of 2,193.24 MXN. Watch SAN1/N chart and read a more detailed SANOFI stock forecast: see what analysts think of SANOFI and suggest that you do with its stocks.
SAN1/N stock is 1.34% volatile and has beta coefficient of 0.68. Track SANOFI stock price on the chart and check out the list of the most volatile stocks — is SANOFI there?
Today SANOFI has the market capitalization of 2.48 T, it has increased by 1.06% over the last week.
Yes, you can track SANOFI financials in yearly and quarterly reports right on TradingView.
SAN1/N net income for the last half-year is 71.53 B MXN, while the previous report showed 44.13 B MXN of net income which accounts for 62.10% change. Track more SANOFI financial stats to get the full picture.
Yes, SAN1/N dividends are paid annually. The last dividend per share was 68.23 MXN. As of today, Dividend Yield (TTM)% is 4.05%. Tracking SANOFI dividends might help you take more informed decisions.
SANOFI dividend yield was 4.18% in 2024, and payout ratio reached 88.23%. The year before the numbers were 4.19% and 87.16% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 11, 2025, the company has 84.59 K employees. See our rating of the largest employees — is SANOFI on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SANOFI EBITDA is 283.52 B MXN, and current EBITDA margin is 31.98%. See more stats in SANOFI financial statements.
Like other stocks, SAN1/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SANOFI stock right from TradingView charts — choose your broker and connect to your account.